MYGN

4.79

5.71% -0.29

Vorhandelsmarkt: 4.53 -0.26 -5.43%

Myriad Genetics Inc (MYGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MYGN? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$5.08

Offen:

$5.04

24-Stunden-Volumen:

1.20M

Relative Volume:

0.74

Marktkapitalisierung:

$452.38M

Einnahmen:

$824.50M

Nettoeinkommen (Verlust:

$-365.90M

KGV:

-1.2117

EPS:

-3.9531

Netto-Cashflow:

$-25.60M

1W Leistung:

-4.20%

1M Leistung:

+2.79%

6M Leistung:

-40.50%

1J Leistung:

-34.29%

1-Tages-Spanne:

$4.545

$5.065

1-Wochen-Bereich:

$4.545

$5.31

52-Wochen-Spanne:

$3.76

$8.59

Myriad Genetics Inc Stock (MYGN) Company Profile

Firmenname

Myriad Genetics Inc

Sektor

Healthcare (1111)

Branche

Diagnostics & Research (52)

Telefon

801-584-3600

Adresse

322 NORTH 2200 WEST, SALT LAKE CITY, UT

Mitarbeiter

2,700

Twitter

@myriadgenetics

Nächster Verdiensttermin

2026-05-05

Neueste SEC-Einreichungen

MYGN's Discussions on Twitter

Compare MYGN vs TMO, DHR, IDXX, A, WAT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MYGN Myriad Genetics Inc	4.79	471.27M	824.50M	-365.90M	-25.60M	-3.9531
TMO Thermo Fisher Scientific Inc	466.70	194.94B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	178.57	137.69B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	560.93	45.19B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	114.42	34.50B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	311.20	32.91B	3.17B	642.63M	516.49M	10.77

Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-21	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2025-05-08	Herabstufung	Wolfe Research	Outperform → Peer Perform
2025-05-07	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-04-09	Herabstufung	Guggenheim	Buy → Neutral
2025-03-12	Hochstufung	Piper Sandler	Neutral → Overweight
2025-02-12	Eingeleitet	Craig Hallum	Buy
2024-12-10	Eingeleitet	UBS	Neutral
2024-12-09	Herabstufung	Leerink Partners	Outperform → Market Perform
2024-09-19	Eingeleitet	Morgan Stanley	Equal-Weight
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-27	Eingeleitet	Scotiabank	Sector Outperform
2024-06-03	Fortgesetzt	Jefferies	Underperform
2024-05-08	Hochstufung	Leerink Partners	Market Perform → Outperform
2023-12-21	Fortgesetzt	Piper Sandler	Neutral
2023-12-19	Eingeleitet	Wells Fargo	Equal Weight
2023-12-14	Eingeleitet	Guggenheim	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Underweight
2023-05-23	Hochstufung	Goldman	Sell → Buy
2023-01-18	Hochstufung	Raymond James	Mkt Perform → Outperform
2022-10-06	Eingeleitet	Stephens	Equal-Weight
2021-10-15	Fortgesetzt	Cowen	Market Perform
2021-06-15	Eingeleitet	Raymond James	Mkt Perform
2021-06-03	Eingeleitet	Goldman	Sell
2019-09-26	Herabstufung	BofA/Merrill	Neutral → Underperform
2019-08-14	Herabstufung	Piper Jaffray	Overweight → Neutral
2019-08-02	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-08-01	Hochstufung	Barclays	Underweight → Equal Weight
2019-07-29	Herabstufung	Needham	Strong Buy → Hold
2019-07-09	Herabstufung	Cowen	Outperform → Market Perform
2019-03-12	Bestätigt	Needham	Strong Buy
2019-01-03	Eingeleitet	Needham	Strong Buy
2018-11-30	Hochstufung	Goldman	Sell → Neutral
2018-10-10	Hochstufung	Piper Jaffray	Neutral → Overweight
2018-07-11	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2018-03-21	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2018-01-29	Eingeleitet	Goldman	Sell
2018-01-22	Bestätigt	Barclays	Equal Weight
2018-01-05	Eingeleitet	BTIG Research	Buy
2017-10-02	Fortgesetzt	Leerink Partners	Mkt Perform
2017-08-09	Bestätigt	Barclays	Equal Weight
2017-02-08	Hochstufung	Ladenburg Thalmann	Sell → Neutral
2017-01-18	Eingeleitet	Deutsche Bank	Sell
2016-10-10	Herabstufung	Ladenburg Thalmann	Neutral → Sell

Alle ansehen

Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten

Apr 23, 2026

Forbes ranks Myriad Genetics among top U.S. employers for company culture in 2026 - Traders Union

Apr 23, 2026

Apr 22, 2026

Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 - ChartMill

Apr 16, 2026

Apr 15, 2026

Myriad Genetics, Inc. (NASDAQ:MYGN) Sees Significant Decline in Short Interest - MarketBeat

Apr 15, 2026

Myriad Genetics (NASDAQ: MYGN) COO has 1,069 shares withheld for RSU taxes - Stock Titan

Apr 15, 2026

Tax withholding trims Myriad Genetics (MYGN) CSO stake by 946 shares - Stock Titan

Apr 15, 2026

Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by TD Cowen - MarketBeat

Apr 15, 2026

Apr 14, 2026

[ARS] MYRIAD GENETICS INC SEC Filing - Stock Titan

Apr 14, 2026

Myriad Genetics (NASDAQ: MYGN) sets 2026 votes and outlines cancer-focused growth - Stock Titan

Apr 14, 2026

Myriad Genetics Expands MyChoice Test Access for Prostate Cancer Patients in Japan - National Today

Apr 14, 2026

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan - Bitget

Apr 14, 2026

GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 - Yahoo Finance

Apr 14, 2026

Myriad Genetics jumps after Q4 beat; sees Q1 revenue rising 2%–4% Y/Y - MSN

Apr 14, 2026

Japan clears Myriad test for prostate cancer patients using Lynparza - Stock Titan

Apr 14, 2026

Apr 13, 2026

Sectors Review: What is the next catalyst for Myriad Genetics IncPortfolio Return Report & Low Risk High Reward Ideas - baoquankhu1.vn

Apr 13, 2026

Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? - MSN

Apr 13, 2026

Apr 09, 2026

Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS INC. lobbying was just disclosed - Quiver Quantitative

Apr 09, 2026

Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting - ChartMill

Apr 09, 2026

Aberdeen Group plc Purchases 246,748 Shares of Myriad Genetics, Inc. $MYGN - MarketBeat

Apr 09, 2026

Apr 08, 2026

Can Myriad Genetics Inc maintain its current growth rate2026 Opening Moves & Long Hold Capital Preservation Tips - baoquankhu1.vn

Apr 08, 2026

Trend Report: Can Myriad Genetics Inc maintain its current growth rate2026 Opening Moves & Long Hold Capital Preservation Tips - baoquankhu1.vn

Apr 08, 2026

Market Outlook: Whats next for Myriad Genetics Inc stockMarket Trend Report & AI Optimized Trade Strategies - baoquankhu1.vn

Apr 08, 2026

MYGN Technical Analysis | Trend, Signals & Chart Patterns | MYRIAD GENETICS INC (NASDAQ:MYGN) - ChartMill

Apr 08, 2026

Apr 07, 2026